Kou, X. et al. Exocrine pancreas regeneration modifies original pancreas to alleviate diabetes in mouse models. Sci. Transl Med. 14, eabg9170 (2022).
Cho, J., D’Antuono, M., Glicksman, M., Wang, J. & Jonklaas, J. A review of clinical trials: mesenchymal stem cell transplant therapy in type 1 and type 2 diabetes mellitus. Am. J. Stem. Cells 7, 82–93 (2018).
CAS PubMed PubMed Central Google Scholar
Shapiro, A. M., Pokrywczynska, M. & Ricordi, C. Clinical pancreatic islet transplantation. Nat. Rev. Endocrinol. 13, 268–277 (2017).
Khatri, R., Petry, S. F. & Linn, T. Intrapancreatic MSC transplantation facilitates pancreatic islet regeneration. Stem Cell Res. Ther. 12, 121 (2021).
Suk, K. et al. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: a key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death. J. Immunol. 166, 4481–4489 (2001).
Hunter, C. A. & Jones, S. A. IL-6 as a keystone cytokine in health and disease. Nat. Immunol. 16, 448–457 (2015).
Rajendran, S. et al. IL-6 is present in beta and alpha cells in human pancreatic islets: Expression is reduced in subjects with type 1 diabetes. Clin. Immunol. 211, 108320 (2020).
留言 (0)